DAPERNO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 525
EU - Europa 236
AS - Asia 111
AF - Africa 7
OC - Oceania 2
SA - Sud America 2
Totale 883
Nazione #
US - Stati Uniti d'America 520
IT - Italia 82
IE - Irlanda 44
CN - Cina 39
SE - Svezia 30
SG - Singapore 25
FI - Finlandia 20
GB - Regno Unito 14
IN - India 13
UA - Ucraina 10
FR - Francia 9
VN - Vietnam 9
HK - Hong Kong 8
NL - Olanda 8
DE - Germania 6
CA - Canada 5
KR - Corea 5
EG - Egitto 4
IR - Iran 3
JP - Giappone 3
PH - Filippine 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
DK - Danimarca 2
EE - Estonia 2
ES - Italia 2
NG - Nigeria 2
PL - Polonia 2
TH - Thailandia 2
AT - Austria 1
CH - Svizzera 1
GR - Grecia 1
SN - Senegal 1
TW - Taiwan 1
Totale 883
Città #
Chandler 121
Ann Arbor 100
Dublin 44
Fairfield 29
Beijing 21
Singapore 16
Ashburn 15
Houston 12
Lappeenranta 12
Nyköping 12
Torino 12
Seattle 10
Princeton 9
Medford 8
Dong Ket 7
Jacksonville 7
Woodbridge 7
Cambridge 6
Milan 6
Turin 6
Dearborn 5
Hong Kong 5
New Delhi 5
Ottawa 5
Pisa 5
Redwood City 5
Villeurbanne 5
Appiano Gentile 4
Boston 4
Helsinki 4
Nijmegen 4
Phoenix 4
Wilmington 4
Boardman 3
Padova 3
Selvazzano Dentro 3
Seoul 3
Abuja 2
Albany 2
Alexandria 2
Amsterdam 2
Baltimore 2
Brussels 2
Changchun 2
Chiang Mai 2
Gurgaon 2
Hangzhou 2
Hefei 2
London 2
Nanjing 2
New York 2
Nuremberg 2
Odense 2
Pinagbuhatan 2
Rome 2
Sale 2
San Diego 2
Santa Clara 2
Sterling 2
Tallinn 2
Warsaw 2
Washington 2
Acqui Terme 1
Athens 1
Atlanta 1
Birmingham 1
Bronx 1
Cagliari 1
Cairo 1
Cartura 1
Central District 1
Chengdu 1
Cleveland 1
Collegeville 1
Como 1
Council Bluffs 1
Dalian 1
Delhi 1
Düsseldorf 1
Edinburgh 1
Fremont 1
Fuzhou 1
Garden City 1
Godalming 1
Grugliasco 1
Guangzhou 1
Haikou 1
Harbin 1
Hebei 1
Jasaan 1
Jouy-le-moutier 1
Kunming 1
Lausanne 1
Mashtul as Suq 1
Melbourne 1
Mountain Home 1
Norwalk 1
Ossona 1
Pescara 1
Philadelphia 1
Totale 619
Nome #
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 142
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 128
Mo1920 – Results of Interim Analysis of a Retrospective Igibd Study on Adalimumab Use in Real Practice in Italy: the Real-Life Clinical Effectiveness of Adalimumab in Ulcerative Colitis (REALADA-UC) Study 120
Application of multiple laboratory tests for Mycobacterium avium ssp. paratuberculosis detection in Crohn's disease patient specimens [*V. Allizond is the corresponding author] 118
P. 06.1 RELATIONSHIP BETWEEN NOD2/CARD15 GENE POLYMORPHISMS AND RESPONSE TO ANTI-TNF AGENTS IN INFLAMMATORY BOWEL DISEASES: RESULTS OF A CLINICAL COHORT STUDY 88
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 77
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 63
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 61
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 48
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy 36
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 21
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 16
Totale 918
Categoria #
all - tutte 3.268
article - articoli 0
book - libri 0
conference - conferenze 380
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 2 1 9 1 6 6 2 1 6 2 11
2020/2021132 6 8 7 5 30 12 3 11 6 17 10 17
2021/2022199 2 1 3 6 13 20 36 32 25 16 28 17
2022/2023318 33 33 9 22 38 58 17 25 54 5 14 10
2023/2024119 18 17 8 9 6 8 6 11 1 22 3 10
2024/202529 3 26 0 0 0 0 0 0 0 0 0 0
Totale 918